Q1 2024

Source filing unavailable

Q1 2024 · —

Revenue

$72.82K

no prior Q1 2023 on file

Net Income

-$181.79K

N/M vs Q1 2023

EPS Diluted

-$0.00

no prior Q1 2023 on file

Gross Profit$64,001—

Operating Income-$176,784—

Operating Cash Flow-$74,620

Same quarter

Metric	Q1 2024	Q1 2023	Q1 2012	Q1 2011
Revenue	$72.82K	—	$17.29M	$21.19M
Net Income	-$181.79K	-$212.03K	$3.10M	$3.98M
EPS Diluted	-$0.00	—	$0.24	$0.31

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Cannabis Bioscience International Holdings, Inc. · CIK 1411057 · Engraved from SEC EDGAR